JB pharma strengthens its position in gastroenterology with launch of RANRAFT
Gastroesophageal reflux disease (GERD), affects up to 1 in 5 Indian patients, causes heartburn, acid reflux and impacts the quality of life. It is worsened with the consumption of certain non-vegetarian food, spices, tobacco consumption etc.Hence, in this endeavour, JB Pharma, makers of the popular drug Rantac strengthens its presence in the area of gastroenterology, by launching a...
Gastroesophageal reflux disease (GERD), affects up to 1 in 5 Indian patients, causes heartburn, acid reflux and impacts the quality of life. It is worsened with the consumption of certain non-vegetarian food, spices, tobacco consumption etc.
Hence, in this endeavour, JB Pharma, makers of the popular drug Rantac strengthens its presence in the area of gastroenterology, by launching a unique formulation called RANRAFT to provide quick relief by neutralizing acid and preventing acid reflux.
For more details, check out the link given below:
JB Pharma Strengthens Its Position In Gastroenterology With Launch Of RANRAFT
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd